J&J, AstraZeneca explore modifying Covid vaccines in response to rare blood clot issue, report says
July 13, 2021 at 09:17 AM EDT
The blood clotting, which some scientists are now calling vaccine-induced immune thrombotic thrombocytopenia, or VITT, has been linked to both shots.
